HBP-347

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameHBP-347
Drug Alias NameHBP-347
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeat shock protein HSP90 modulators
TargetsHeat shock protein HSP90
Therapy Area/IndicationsGlioblastomaLymphoma, T-Cell, Cutaneous
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesHy Biopharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHy Biopharma
Active IndicationsN/A
Inactive IndicationsGlioblastomaLymphoma, T-Cell, Cutaneous

Other Information

ATC CodeN/A
Related LinksN/A